PDS Biotechnology Q1 2026 Earnings EPS Beat Highlights Progress Despite PreRevenue Status HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips NFBK Q1 2026 Earnings EPS Surpasses Estimates by 417 as Net Interest Margin Holds Steady Target Q1 2026 Earnings EPS of 171 Amid Mixed Consumer Environment CSL Q1 2026 Earnings EPS Surpasses Estimates by 78 Stock Rises Modestly MTDR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response